JP2020534284A5 - - Google Patents

Download PDF

Info

Publication number
JP2020534284A5
JP2020534284A5 JP2020515680A JP2020515680A JP2020534284A5 JP 2020534284 A5 JP2020534284 A5 JP 2020534284A5 JP 2020515680 A JP2020515680 A JP 2020515680A JP 2020515680 A JP2020515680 A JP 2020515680A JP 2020534284 A5 JP2020534284 A5 JP 2020534284A5
Authority
JP
Japan
Prior art keywords
protein
composition according
rsv
composition
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020515680A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020534284A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/051054 external-priority patent/WO2019055768A1/en
Publication of JP2020534284A publication Critical patent/JP2020534284A/ja
Publication of JP2020534284A5 publication Critical patent/JP2020534284A5/ja
Pending legal-status Critical Current

Links

JP2020515680A 2017-09-15 2018-09-14 ワクチン、並びに、呼吸器合胞体ウイルス(rsv)感染症を予防するためのワクチンの作製方法及び使用方法 Pending JP2020534284A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762559167P 2017-09-15 2017-09-15
US62/559,167 2017-09-15
PCT/US2018/051054 WO2019055768A1 (en) 2017-09-15 2018-09-14 VACCINES AND METHODS OF MAKING AND USING VACCINES FOR THE PREVENTION OF SYNCYTIAL RESPIRATORY VIRUS (RSV) INFECTIONS

Publications (2)

Publication Number Publication Date
JP2020534284A JP2020534284A (ja) 2020-11-26
JP2020534284A5 true JP2020534284A5 (https=) 2021-10-21

Family

ID=65723867

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020515680A Pending JP2020534284A (ja) 2017-09-15 2018-09-14 ワクチン、並びに、呼吸器合胞体ウイルス(rsv)感染症を予防するためのワクチンの作製方法及び使用方法

Country Status (8)

Country Link
US (1) US20200276297A1 (https=)
EP (1) EP3681523A4 (https=)
JP (1) JP2020534284A (https=)
KR (1) KR20200096904A (https=)
CN (1) CN111344008A (https=)
AU (1) AU2018331467A1 (https=)
CA (1) CA3075990A1 (https=)
WO (1) WO2019055768A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114957407A (zh) 2019-04-02 2022-08-30 赛诺菲 抗原性多聚呼吸道合胞病毒多肽
CN112226450B (zh) * 2020-08-25 2022-10-14 北京交通大学 一种共表达呼吸道合胞病毒融合前蛋白和黏附糖蛋白的复制缺陷型腺病毒载体疫苗
EP4410969A4 (en) * 2021-09-29 2026-01-21 Sk Bioscience Co Ltd RECOMINED LIVE ATTENUATED RSV VACCINE STRAIN AND ITS PRODUCTION PROCESS
KR102806300B1 (ko) * 2023-01-13 2025-05-14 클립스비엔씨 주식회사 호흡기 신시치아 바이러스 변이체를 포함하는 호흡기 신시치아 바이러스 백신용 융합단백질 및 이의 제조방법
CN118930654A (zh) * 2023-05-12 2024-11-12 中国科学院微生物研究所 一种呼吸道合胞病毒抗原制备方法和应用
CN117720628A (zh) * 2023-10-12 2024-03-19 中国科学院微生物研究所 一种呼吸道合胞病毒二价抗原制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1224462A (zh) * 1996-07-15 1999-07-28 美国政府健康及人类服务部 从克隆的核苷酸序列制备减毒呼吸道合胞病毒疫苗的方法
IL145797A0 (en) * 1999-04-13 2002-07-25 Government Of The Us Dept Of H Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences
WO2001092548A2 (en) * 2000-06-01 2001-12-06 St. Jude Children's Research Hospital Vaccine and gene therapy vector and methods of use thereof
US20050048030A1 (en) * 2001-09-28 2005-03-03 Raymond Pickles Paramyxoviruses as gene transfer vectors to lung cells
CN1646684B (zh) * 2002-02-21 2010-10-06 免疫医疗疫苗公司 重组副流感病毒表达系统以及包含源自间质肺病毒的异种抗原的疫苗
EP1527087B2 (en) * 2002-07-26 2013-07-17 Her Majesty, The Queen in Right of Canada, as Represented by The Minister of Health Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers
CN1871355B (zh) * 2003-06-09 2011-12-14 惠氏 从cDNA中回收非节段性负链RNA病毒的改进方法
ATE555208T1 (de) * 2003-06-13 2012-05-15 Apath Llc Replikon eines negativsträngigen rna-virus
US8287878B2 (en) * 2004-04-09 2012-10-16 Wyeth Llc Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
US8772256B2 (en) * 2006-11-30 2014-07-08 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Codon modified immunogenic compositions and methods of use
WO2009025770A2 (en) * 2007-08-17 2009-02-26 Wyeth A heterologous prime-boost immunization regimen
US20090162321A1 (en) * 2007-12-20 2009-06-25 Wyeth Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein
CA2742086A1 (en) * 2008-11-05 2010-05-14 Merck Sharp & Dohme Corp. Live, attenuated respiratory syncytial virus
ES2749381T3 (es) * 2014-03-01 2020-03-20 Univ Texas Vectores víricos Isfahan recombinantes
CN106659777A (zh) * 2014-06-13 2017-05-10 葛兰素史密丝克莱恩生物有限公司 免疫原性组合产品

Similar Documents

Publication Publication Date Title
JP2020534284A5 (https=)
JP2020022459A5 (https=)
JP2019530462A5 (https=)
PH12018501912A1 (en) Vaccine against rsv
JP2015096070A5 (https=)
JP2017048194A5 (https=)
CN106659777A8 (zh) 免疫原性组合产品
JP2018520997A5 (https=)
JP2017035093A5 (https=)
JP2013507907A5 (https=)
JP2016146837A5 (https=)
ATE419369T1 (de) Chimäre mensch-rinder respiratory syncytial virus vakzinen
JP2019146574A5 (https=)
JP2015533841A5 (https=)
JP2008500399A5 (https=)
JP2016533332A5 (https=)
JP2014507146A5 (https=)
JP2015524422A5 (https=)
JP2015501840A5 (https=)
JP2015509707A5 (https=)
JP2012511579A5 (https=)
RU2012105308A (ru) Композиции белка f rsv и способы их получения
EA202090738A1 (ru) Способ безопасного индуцирования иммунитета против rsv
JP2010508030A5 (https=)
JP2023100654A5 (https=)